FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply
This article was originally published in The Tan Sheet
Executive Summary
FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney
You may also be interested in...
AHPA Says H1N1 Enforcement Tactics Would Work To Find Hidden Steroids
The American Herbal Products Association urges FDA to crack down on illegal steroids masquerading as dietary supplements with the "efficient" enforcement tactics the agency uses to pursue fraudulent H1N1 flu products
FDA Enforcement Follow-Through Could Thin Out Violators
FDA's emphasis on follow-through in its revamped enforcement strategy may help weed out bad actors from legitimate industry
FDA Learned Consumer Protection Lesson From 2004 Flu Scare
The roster of teams FDA assembled to respond to the 2009-N1H1 flu outbreak includes a consumer protection group to identify potentially dangerous products marketed as cures for the virus